Back
KLBF - Kalbe Farma

KLBF – Allocating IDR1 tn capex to increase production capacity

23 May 2025

KLBF – Allocating IDR1 tn capex to increase production capacity Kalbe Farma (KLBF) has allocated capex of IDR1 tn for asset maintenance and production capacity expansion, including through its subsidiary, Global Onkolab Farma's cancer drug factory. Previously, KLBF had just distributed a cash dividend of IDR1.7 tn, or IDR36 per share. (Source : Bisnis Indonesia)

Related Research

Healthcare
KLBF - Sustaining growth further, after solid 1H25 results
Andre Suntono 28 August 2025 See Detail
Consumer
KLBF - Performa solid pada kuartal pertama tahun 2022
Winny Rahardja 10 May 2022 See Detail
Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 August 2022 See Detail